Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons - PubMed (original) (raw)
Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons
Bruce A Mungall et al. Virus Res. 2004 Jul.
Abstract
Neuraminidase (NA) inhibitors (NI) have recently been licensed for the prophylaxis and treatment of influenza virus infection in humans. This study has utilized a new chemiluminescent (CL) neuraminidase assay to routinely monitor more than a thousand influenza field isolates collected worldwide during the 2000-2002 seasons for susceptibility to both licensed NIs, zanamivir, and oseltamivir by determining the 50% inhibitory concentration (IC50). Our data demonstrated that influenza A viruses of the N2 subtype were less susceptible to zanamivir, but not oseltamivir, than those of the N1 subtype such that 41 of 45 confirmed H1N2 isolates could be reliably differentiated from H1N1 viruses based on their zanamivir susceptibility. Pre-titration of influenza A viruses appeared to have no effect on IC50 determined for either NI, while pre-titration of influenza B viruses significantly reduced oseltamivir IC50 and increased zanamivir IC50. Influenza B viruses were less susceptible to either compound than type A isolates. The CL assay is a rapid and reliable method for screening large numbers of influenza isolates for NI susceptibility. Reassortant viruses of the H1N2 subtype that started to circulate worldwide during the 2001-2002 season can be reliably separated from H1N1 viruses based on their zanamivir susceptibility, enabling large scale screening of H1 isolates for determining the prevalence of such reassortants.
Similar articles
- Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
Hurt AC, Barr IG, Hartel G, Hampson AW. Hurt AC, et al. Antiviral Res. 2004 Apr;62(1):37-45. doi: 10.1016/j.antiviral.2003.11.008. Antiviral Res. 2004. PMID: 15026200 - Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW. Hurt AC, et al. Commun Dis Intell Q Rep. 2003;27(4):542-7. Commun Dis Intell Q Rep. 2003. PMID: 15508516 - Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY, Hayden FG. Aoki FY, et al. Clin Pharmacokinet. 1999;36 Suppl 1:v-ix. Clin Pharmacokinet. 1999. PMID: 10429834 Review. No abstract available. - [Critical review of anti-influenza drugs].
van Loon FP, Voordouw AC, Simonian S, Koopmans PP. van Loon FP, et al. Ned Tijdschr Geneeskd. 2000 Jan 22;144(4):165-7. Ned Tijdschr Geneeskd. 2000. PMID: 10668542 Review. Dutch.
Cited by
- Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
Farrukee R, Gunalan V, Maurer-Stroh S, Reading PC, Hurt AC. Farrukee R, et al. J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14. J Virol. 2022. PMID: 35867563 Free PMC article. - EGCG induces β-defensin 3 against influenza A virus H1N1 by the MAPK signaling pathway.
Mou Q, Jiang Y, Zhu L, Zhu Z, Ren T. Mou Q, et al. Exp Ther Med. 2020 Oct;20(4):3017-3024. doi: 10.3892/etm.2020.9047. Epub 2020 Jul 24. Exp Ther Med. 2020. PMID: 32855668 Free PMC article. - Hygrothermal environment may cause influenza pandemics through immune suppression.
Wu XL, Luo YH, Chen J, Yu B, Liu KL, He JX, Lu SH, Li JX, Wu S, Jiang ZY, Chen XY. Wu XL, et al. Hum Vaccin Immunother. 2015;11(11):2641-6. doi: 10.1080/21645515.2015.1084452. Hum Vaccin Immunother. 2015. PMID: 26359946 Free PMC article. - Immunologic mechanism of Patchouli alcohol anti-H1N1 influenza virus may through regulation of the RLH signal pathway in vitro.
Wu XL, Ju DH, Chen J, Yu B, Liu KL, He JX, Dai CQ, Wu S, Chang Z, Wang YP, Chen XY. Wu XL, et al. Curr Microbiol. 2013 Oct;67(4):431-6. doi: 10.1007/s00284-013-0381-y. Epub 2013 May 17. Curr Microbiol. 2013. PMID: 23680974 - Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
Okomo-Adhiambo M, Sleeman K, Lysén C, Nguyen HT, Xu X, Li Y, Klimov AI, Gubareva LV. Okomo-Adhiambo M, et al. Influenza Other Respir Viruses. 2013 Sep;7(5):645-58. doi: 10.1111/irv.12113. Epub 2013 Apr 10. Influenza Other Respir Viruses. 2013. PMID: 23575174 Free PMC article.